Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-09-02
2008-09-02
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S324000, C514S909000
Reexamination Certificate
active
10898490
ABSTRACT:
Disclosed is a method of using synthetic analogs of natriuretic peptides and more particularly to synthetic linear peptide analogs as pro-lipolytic, as anti-obesity agents, and as intermediates for or modulators of such useful compounds. Inhibitors to nprC are disclosed to treat or prevent adipose accumulation in mammals.
REFERENCES:
Matsukawa et al., Proc. Natl. Acad. Sci. USA 96: 7403-7408, 1999.
Sun et al., Am J. Phys. Renal Phys. 282 : 220-227, 2002.
Campese et al Hypertension 28: 335-340, 1996.
Rebbeck et al., Nature Review Genetics 5: 589-97, 2004.
Flier et al., “Leptin Expression and action: New experimental paradigms”, PNAS, vol. 94, pp. 4242-4245 (Apr. 1997).
Samad et al., “Tissue factor gene expression in the adipose tissues of obese mice”, Proc. Natl. Acad. Sci. USA, vol. 95, pp. 7591-7596 (Jun. 1998).
Ashar Hena
Chada Kiran K.
Chouinard Roland
Sayed Abu
Chandra Gyan
Cooper & Dunham LLP
Gershik Gary J.
HMGene Inc.
Landsman Robert
LandOfFree
Method of reducing adipocyte growth in a subject in need... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing adipocyte growth in a subject in need..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing adipocyte growth in a subject in need... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3930032